English

SAGENT PHARMACEUTICALS, INC.

EDGAR

SGNT Filing amendment (SC 13G/A) · filed 2016-09-02

58 filing records in this dataset, filed from 2010-12-06 to 2016-09-02. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

41.3 million USD

2011-09-30 · USD

Exact inputs and evidence

Revenue: 41281000 USD Source

Operating margin

-8.75%

2011 Q3 · %

Exact inputs and evidence

Operating Income: -3612000 USD Source
Revenue: 41281000 USD Source

Operating cash flow

-8.62 million USD

2011-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -31150000 USD Source
Operating Cash Flow: -22531000 USD Source

Free cash flow

-8.72 million USD

2011-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -31150000 USD Source
Operating Cash Flow: -22531000 USD Source
Capital Expenditure: 214000 USD Source
Capital Expenditure: 113000 USD Source

Cash and cash equivalents: 15.5 million USD 2016-06-30 Source
Exact value

15524000 USD
Long-term debt including current maturities: 1.62 million USD 2015-12-31 Source
Exact value

1623000 USD
Shares outstanding: 32.9 million shares 2016-06-30 Source
Exact value

32851263 shares

Reported share-count change

0.52% · 169 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

32682230 shares · 2015-06-30· Source
32851263 shares · 2016-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Capital expenditure

9.57 million USD

2015-07-01 – 2016-06-30

Exact inputs and evidence

Capital expenditure: 5057000 USD · 2015-01-01 – 2015-09-30 Source
Capital expenditure: 3193000 USD · 2015-01-01 – 2015-06-30 Source
Capital expenditure: 6711000 USD · 2015-01-01 – 2015-12-31 Source
Capital expenditure: 5057000 USD · 2015-01-01 – 2015-09-30 Source
Capital expenditure: 2339000 USD · 2016-01-01 – 2016-03-31 Source
Capital expenditure: 6052000 USD · 2016-01-01 – 2016-06-30 Source
Capital expenditure: 2339000 USD · 2016-01-01 – 2016-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2016-09-02.

Financial data available through: 2015-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 6 of 11 periods available· newest 2015-12-31
Net income: 6 of 11 periods available· newest 2015-12-31
Operating cash flow: 6 of 11 periods available· newest 2015-12-31
Capital expenditure: 3 of 11 periods available· newest 2015-12-31
Total assets: 5 of 11 periods available· newest 2015-12-31
Total liabilities: 5 of 11 periods available· newest 2015-12-31
Current assets: 5 of 11 periods available· newest 2015-12-31
Current liabilities: 5 of 11 periods available· newest 2015-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2015-12-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2015-12-31
Shares outstanding: 5 of 11 periods available· newest 2015-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
-159.2%

Prior period

USD 36.95 million

2014-01-01 – 2014-12-31
Current period

−USD 21.88 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-21882000 − 36951000 = -58833000 USD

36951000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-21882000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · SAGENT PHARMACEUTICALS, INC. · 2015-12-31 SAGENT PHARMACEUTICALS, INC. (edgar:1369786) Year-over-year change in Net income: -58833000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T08:05:27Z Snapshot: 4f32065e917522e3dba33bed77edceced5ce2597f4e71bb10edad8eb290cfee9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1369786?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -21882000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312516495377/sgnt-20151231.xml#2322144 Filing: 000119312516495377 Input fundies:NetIncome: 36951000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312516495377/sgnt-20151231.xml#225784 Filing: 000119312516495377
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-133.9%

Prior period

USD 22.2 million

2014-01-01 – 2014-12-31
Current period

−USD 7.52 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-7523000 − 22199000 = -29722000 USD

22199000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-7523000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · SAGENT PHARMACEUTICALS, INC. · 2015-12-31 SAGENT PHARMACEUTICALS, INC. (edgar:1369786) Year-over-year change in Operating cash flow: -29722000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T08:05:27Z Snapshot: 4f32065e917522e3dba33bed77edceced5ce2597f4e71bb10edad8eb290cfee9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1369786?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -7523000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312516495377/sgnt-20151231.xml#1060844 Filing: 000119312516495377 Input fundies:OperatingCashFlow: 22199000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312516495377/sgnt-20151231.xml#215856 Filing: 000119312516495377
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+58.2%

Prior period

USD 4.24 million

2014-01-01 – 2014-12-31
Current period

USD 6.71 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

6711000 − 4242000 = 2469000 USD

4242000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
6711000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · SAGENT PHARMACEUTICALS, INC. · 2015-12-31 SAGENT PHARMACEUTICALS, INC. (edgar:1369786) Year-over-year change in Capital expenditure: 2469000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T08:05:27Z Snapshot: 4f32065e917522e3dba33bed77edceced5ce2597f4e71bb10edad8eb290cfee9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1369786?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 6711000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312516495377/sgnt-20151231.xml#2315019 Filing: 000119312516495377 Input fundies:CapitalExpenditure: 4242000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312516495377/sgnt-20151231.xml#218936 Filing: 000119312516495377
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2010 2010-01-01 – 2010-12-31	−USD 24.5 million Exact value Exact value: -24495000 USD 2010-01-01 – 2010-12-31: -24495000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SAGENT PHARMACEUTICALS, INC. · 2010-12-31 SAGENT PHARMACEUTICALS, INC. (edgar:1369786) Net Income: -24495000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T08:05:27Z Snapshot: 4f32065e917522e3dba33bed77edceced5ce2597f4e71bb10edad8eb290cfee9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1369786/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24495000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312513112600/sgnt-20121231.xml#130845 Filing: 000119312513112600 The citation records this snapshot. The page link may show a newer release later.	−USD 27.8 million Exact value Exact value: -27797000 USD 2010-01-01 – 2010-12-31: -27797000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SAGENT PHARMACEUTICALS, INC. · 2010-12-31 SAGENT PHARMACEUTICALS, INC. (edgar:1369786) Operating Cash Flow: -27797000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T08:05:27Z Snapshot: 4f32065e917522e3dba33bed77edceced5ce2597f4e71bb10edad8eb290cfee9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1369786/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -27797000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312513112600/sgnt-20121231.xml#122155 Filing: 000119312513112600 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2011 2011-01-01 – 2011-12-31	−USD 26.42 million Exact value Exact value: -26422000 USD 2011-01-01 – 2011-12-31: -26422000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SAGENT PHARMACEUTICALS, INC. · 2011-12-31 SAGENT PHARMACEUTICALS, INC. (edgar:1369786) Net Income: -26422000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T08:05:27Z Snapshot: 4f32065e917522e3dba33bed77edceced5ce2597f4e71bb10edad8eb290cfee9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1369786/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -26422000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312514089369/sgnt-20131231.xml#144461 Filing: 000119312514089369 The citation records this snapshot. The page link may show a newer release later.	−USD 20.42 million Exact value Exact value: -20418000 USD 2011-01-01 – 2011-12-31: -20418000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SAGENT PHARMACEUTICALS, INC. · 2011-12-31 SAGENT PHARMACEUTICALS, INC. (edgar:1369786) Operating Cash Flow: -20418000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T08:05:27Z Snapshot: 4f32065e917522e3dba33bed77edceced5ce2597f4e71bb10edad8eb290cfee9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1369786/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20418000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312514089369/sgnt-20131231.xml#135633 Filing: 000119312514089369 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2012 2012-01-01 – 2012-12-31	−USD 16.82 million Exact value Exact value: -16817000 USD 2012-01-01 – 2012-12-31: -16817000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SAGENT PHARMACEUTICALS, INC. · 2012-12-31 SAGENT PHARMACEUTICALS, INC. (edgar:1369786) Net Income: -16817000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T08:05:27Z Snapshot: 4f32065e917522e3dba33bed77edceced5ce2597f4e71bb10edad8eb290cfee9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1369786/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16817000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312515093810/sgnt-20141231.xml#2242896 Filing: 000119312515093810 The citation records this snapshot. The page link may show a newer release later.	−USD 20.12 million Exact value Exact value: -20122000 USD 2012-01-01 – 2012-12-31: -20122000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SAGENT PHARMACEUTICALS, INC. · 2012-12-31 SAGENT PHARMACEUTICALS, INC. (edgar:1369786) Operating Cash Flow: -20122000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T08:05:27Z Snapshot: 4f32065e917522e3dba33bed77edceced5ce2597f4e71bb10edad8eb290cfee9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1369786/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20122000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312515093810/sgnt-20141231.xml#2233036 Filing: 000119312515093810 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2013 2013-01-01 – 2013-12-31	USD 29.59 million Exact value Exact value: 29594000 USD 2013-01-01 – 2013-12-31: 29594000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SAGENT PHARMACEUTICALS, INC. · 2013-12-31 SAGENT PHARMACEUTICALS, INC. (edgar:1369786) Net Income: 29594000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T08:05:27Z Snapshot: 4f32065e917522e3dba33bed77edceced5ce2597f4e71bb10edad8eb290cfee9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1369786/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: 29594000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312516495377/sgnt-20151231.xml#189019 Filing: 000119312516495377 The citation records this snapshot. The page link may show a newer release later.	USD 49.55 million Exact value Exact value: 49551000 USD 2013-01-01 – 2013-12-31: 49551000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SAGENT PHARMACEUTICALS, INC. · 2013-12-31 SAGENT PHARMACEUTICALS, INC. (edgar:1369786) Operating Cash Flow: 49551000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T08:05:27Z Snapshot: 4f32065e917522e3dba33bed77edceced5ce2597f4e71bb10edad8eb290cfee9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1369786/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 49551000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312516495377/sgnt-20151231.xml#179404 Filing: 000119312516495377 The citation records this snapshot. The page link may show a newer release later.	USD 1.1 million Exact value Exact value: 1103000 USD 2013-01-01 – 2013-12-31: 1103000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SAGENT PHARMACEUTICALS, INC. · 2013-12-31 SAGENT PHARMACEUTICALS, INC. (edgar:1369786) Capital Expenditure: 1103000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T08:05:27Z Snapshot: 4f32065e917522e3dba33bed77edceced5ce2597f4e71bb10edad8eb290cfee9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1369786/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1103000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312516495377/sgnt-20151231.xml#182481 Filing: 000119312516495377 The citation records this snapshot. The page link may show a newer release later.	USD 48.45 million Calculation and evidence 49551000 − 1103000 USD Exact free cash flow: 48448000 USD 2013-01-01 – 2013-12-31: 49551000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 1103000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SAGENT PHARMACEUTICALS, INC. · 2013-12-31 SAGENT PHARMACEUTICALS, INC. (edgar:1369786) Free cash flow: 48448000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T08:05:27Z Snapshot: 4f32065e917522e3dba33bed77edceced5ce2597f4e71bb10edad8eb290cfee9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1369786?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 49551000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312516495377/sgnt-20151231.xml#179404 Filing: 000119312516495377 Input fundies:CapitalExpenditure: 1103000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312516495377/sgnt-20151231.xml#182481 Filing: 000119312516495377 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	USD 36.95 million Exact value Exact value: 36951000 USD 2014-01-01 – 2014-12-31: 36951000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SAGENT PHARMACEUTICALS, INC. · 2014-12-31 SAGENT PHARMACEUTICALS, INC. (edgar:1369786) Net Income: 36951000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T08:05:27Z Snapshot: 4f32065e917522e3dba33bed77edceced5ce2597f4e71bb10edad8eb290cfee9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1369786/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: 36951000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312516495377/sgnt-20151231.xml#225784 Filing: 000119312516495377 The citation records this snapshot. The page link may show a newer release later.	USD 22.2 million Exact value Exact value: 22199000 USD 2014-01-01 – 2014-12-31: 22199000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SAGENT PHARMACEUTICALS, INC. · 2014-12-31 SAGENT PHARMACEUTICALS, INC. (edgar:1369786) Operating Cash Flow: 22199000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T08:05:27Z Snapshot: 4f32065e917522e3dba33bed77edceced5ce2597f4e71bb10edad8eb290cfee9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1369786/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 22199000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312516495377/sgnt-20151231.xml#215856 Filing: 000119312516495377 The citation records this snapshot. The page link may show a newer release later.	USD 4.24 million Exact value Exact value: 4242000 USD 2014-01-01 – 2014-12-31: 4242000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SAGENT PHARMACEUTICALS, INC. · 2014-12-31 SAGENT PHARMACEUTICALS, INC. (edgar:1369786) Capital Expenditure: 4242000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T08:05:27Z Snapshot: 4f32065e917522e3dba33bed77edceced5ce2597f4e71bb10edad8eb290cfee9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1369786/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4242000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312516495377/sgnt-20151231.xml#218936 Filing: 000119312516495377 The citation records this snapshot. The page link may show a newer release later.	USD 17.96 million Calculation and evidence 22199000 − 4242000 USD Exact free cash flow: 17957000 USD 2014-01-01 – 2014-12-31: 22199000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 4242000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SAGENT PHARMACEUTICALS, INC. · 2014-12-31 SAGENT PHARMACEUTICALS, INC. (edgar:1369786) Free cash flow: 17957000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T08:05:27Z Snapshot: 4f32065e917522e3dba33bed77edceced5ce2597f4e71bb10edad8eb290cfee9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1369786?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 22199000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312516495377/sgnt-20151231.xml#215856 Filing: 000119312516495377 Input fundies:CapitalExpenditure: 4242000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312516495377/sgnt-20151231.xml#218936 Filing: 000119312516495377 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 21.88 million Exact value Exact value: -21882000 USD 2015-01-01 – 2015-12-31: -21882000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SAGENT PHARMACEUTICALS, INC. · 2015-12-31 SAGENT PHARMACEUTICALS, INC. (edgar:1369786) Net Income: -21882000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T08:05:27Z Snapshot: 4f32065e917522e3dba33bed77edceced5ce2597f4e71bb10edad8eb290cfee9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1369786/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21882000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312516495377/sgnt-20151231.xml#2322144 Filing: 000119312516495377 The citation records this snapshot. The page link may show a newer release later.	−USD 7.52 million Exact value Exact value: -7523000 USD 2015-01-01 – 2015-12-31: -7523000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SAGENT PHARMACEUTICALS, INC. · 2015-12-31 SAGENT PHARMACEUTICALS, INC. (edgar:1369786) Operating Cash Flow: -7523000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T08:05:27Z Snapshot: 4f32065e917522e3dba33bed77edceced5ce2597f4e71bb10edad8eb290cfee9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1369786/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7523000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312516495377/sgnt-20151231.xml#1060844 Filing: 000119312516495377 The citation records this snapshot. The page link may show a newer release later.	USD 6.71 million Exact value Exact value: 6711000 USD 2015-01-01 – 2015-12-31: 6711000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SAGENT PHARMACEUTICALS, INC. · 2015-12-31 SAGENT PHARMACEUTICALS, INC. (edgar:1369786) Capital Expenditure: 6711000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T08:05:27Z Snapshot: 4f32065e917522e3dba33bed77edceced5ce2597f4e71bb10edad8eb290cfee9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1369786/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6711000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312516495377/sgnt-20151231.xml#2315019 Filing: 000119312516495377 The citation records this snapshot. The page link may show a newer release later.	−USD 14.23 million Calculation and evidence -7523000 − 6711000 USD Exact free cash flow: -14234000 USD 2015-01-01 – 2015-12-31: -7523000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 6711000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SAGENT PHARMACEUTICALS, INC. · 2015-12-31 SAGENT PHARMACEUTICALS, INC. (edgar:1369786) Free cash flow: -14234000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T08:05:27Z Snapshot: 4f32065e917522e3dba33bed77edceced5ce2597f4e71bb10edad8eb290cfee9 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1369786?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7523000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312516495377/sgnt-20151231.xml#1060844 Filing: 000119312516495377 Input fundies:CapitalExpenditure: 6711000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1369786/000119312516495377/sgnt-20151231.xml#2315019 Filing: 000119312516495377 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

58 filings · 1,921 latest values · 1,921 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001369786, 1369786, SGNT, edgar:1369786

Also known as NHS PHARMACEUTICALS, SAGENT PHARMACEUTICALS, INC., Sagent Holding Co., Sagent Pharmaceuticals, Inc.

SAGENT PHARMACEUTICALS, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Capital expenditure

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation